GlassScriptPhysician profile
Eric Fichtenbaum
NPI 1073932091
$3,661.75
in general payments reported to CMS, 2019-2025
16 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $18.92 · 2021: $432 · 2022: $1,101 · 2023: $255 · 2024: $1,351 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180 · Travel and Lodging: $582 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.00 |
| Travel and Lodging | $582.48 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,218.98 | 2022-2025 | Aquabeam System |
| Intuitive Surgical, INC. | $935.51 | 2024 | |
| Teleflex LLC | $634.30 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $220.83 | 2019 | |
| Calyxo, INC. | $151.92 | 2025 | Cvac Aspiration System |
| Foundation Medicine, INC. | $119.73 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $117.43 | 2019 | |
| Myovant Sciences INC. | $100.76 | 2021 | |
| Abbvie INC. | $34.26 | 2021 | |
| Myriad Genetic Laboratories, INC. | $21.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.61 | 2022 | |
| Clarus Therapeutics INC. | $20.97 | 2021 | |
| Neotract INC. | $18.92 | 2020 | |
| Laborie Medical Technologies Corp. | $18.21 | 2023 | |
| Pfizer INC. | $13.82 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fichtenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.